BAVIS_1170x120_1-20

infusion services

Option Care emerges as an independent entity

Option Care emerges as an independent entity

DEERFIELD, Ill. — Walgreens Infusion Services is now Option Care, an independent company and brand, though Walgreens has retained “significant” minority ownership. Madison Dearborn Partners (MDP), a private equity firm based in Chicago, now owns the lion’s share of the new infusion services provider. Paul Mastrapa, chief executive officer of Option Care and the former

Diplomat bulks up in infusion services

FLINT, Mich. — Diplomat Pharmacy, which posted strong financial results for fiscal 2014, is acquiring BioRx LLC, a specialized pharmacy and infusion services company. Based in Cincinnati, BioRx provides treatments for patients with ultra-orphan and rare, chronic diseases. Terms of the agreement call for Diplomat to buy BioRx for $210 million in cash and $105

Walgreens inks deal on infusion services

DEERFIELD, Ill. — Walgreen Co. has signed a definitive agreement with Madison Dearborn Partners, a private equity firm based in Chicago, under which MDP will acquire a majority interest in Walgreens Infusion Services. One of the nation’s largest providers of home and alternate treatment site infusion services, Walgreens Infusion Services has a footprint that includes 89